Background: Preterm labor (PL) is a leading cause of perinatal morbidity and mortality. Different factors can result in preterm labor, including maternal vitamin D. Objectives: Hence, this study aimed to evaluate the level of vitamin D in pregnant women with PL. Methods: This case-control study was conducted on 156 pregnant women (52 cases with PL and 104 controls without PL) in Ali Ibn Abitaleb Hospital, Zahedan, Iran, in 2018. Results: The age was 30.92 ± 5.21 and 29.39 ± 4.86 years in the case and control groups, respectively. There were no significant (P-value > 0.05) differences between the two groups in baseline variables. Vitamin D supplement consumption (P-value = 0.128), sun exposure time (P-value = 0.304), history of admission in pregnancy (P-value = 0.608), and history of vaginal infection (P-value = 0.100) were not significantly different between the two groups. The mean vitamin D level was 30.88 and 31.93 ng/mL in pregnant women with and without PL, respectively, with no significant difference (P-value = 0.591). The mean babies' weight was significantly (P-value > 0.001) higher in the control group than in PL women (3338.75 ± 466.16 vs. 2655.76 ± 393.36 g). Conclusions: Although this study showed no association between vitamin D levels and PL, abnormal vitamin D levels might be related to PL in pregnant women with other comorbidities or risk factors.
Struma ovarii is a rare ovarian lesion characterized by the presence of
thyroid tissue. The symptoms of this tumor are nonspecific and thus
misdiagnosis to other lesions are common. The initial footprint of the
tumor is mostly based on incidental imaging, but definitive diagnosis is
possible based on pathological studies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.